Søgning på udtrykket 'prep' giver 48 resultater
Dokumenter [3]
Sider [3]
Kalender [2]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [+20]
Dokumenter [3]
Fællesregional retningslinje for udlevering af forebyggende medicin mod HIV (PrEP), udgivet af Danske Regioner.
Arrangereret af AIDS-fondet og CHIP
Henvendelse til Danske regioner
Sider [3]
Arbejdsgrupper og udvalg under Dansk Selskab for Infektionsmedicin organiseres med en kerne på typisk 4-8 personer (maks. 10) herunder en tovholder.
Bestyrelsen kan oprette og lukke arbejdsgrupper/udvalg. Ved oprettelse af arbejdsgruppe sender bestyrelsen invitation til infektionsmedicinske centre i alle regioner.
Alle DSI medlemmer, med undtagelse af firma-medlemmer, kan indgå i arbejdsgrupper. Arbejdsgruppens tovholder og sammensætning fremgår her på siden. Arbejdsgruppens tovholder vælges i grupp
e HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era Curr HIV/AIDS Rep. 2015; 12: 6?15.
HIV - persistence on ART & cure research:. Margolis et al: Latency reversal and viral clearance to cure HIV-1. Science. 2016; 253: aaf6517.
PREP og PEP:. Fonner et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations: AIDS 2016 Jul 31;30(12):1973-83. Rodger et al. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-
dling (Lene).
12:00-12:45 Resistens (Ann-Brit Eg Hansen).
12:45-13:30 Frokost.
13:30-14:15 Klinisk håndtering af HIV I (Ole og Lene).
14:15-14.30 Pause.
14:30-15:30 Klinisk håndtering af HIV 2 - cases (Alle).
15:30-15:45 Pause.
15:45-16:30 PrEP, Long acting antiretrovirals og STDs (Gitte Kronborg).
.
Torsdag den 13. oktober.
08:15-09:15 HIV og Komorbiditet/EACS Guidelines (Lene).
09:15-09:30 Pause.
09:30-10:15 Cocomo, danske data vedr HIV og co-morbiditet (Susanne Dam).
10:15-1
Kalender [2]
19. marts 2015, Auditorium 1, Rigshospitalet
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
PLoS One Infectious Diseases
20.09.2023
by Christina M. Kaul, Brandi E. Moore, Emma Kaplan-Lewis, Eunice Casey, Robert A. Pitts, Patricia Pagan Pirallo, Sahnah Lim, Farzana Kapadia, Gabriel M. Cohen, Maria Khan, Ofole Mgbako . Background Long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP) was approved by the U.S. Food and Drug Administration in December 2021. This initial phase of implementation represents a prime opportunity to ensure equitable LAI-PrEP provision to communities often underrepresented in PrEP care before disparities i
PLoS One Infectious Diseases
15.09.2023
by Amanda Jane Blatch-Jones, Alejandra Recio Saucedo, Beth Giddins . Background Preprints are open and accessible scientific manuscript or report that is shared publicly, through a preprint server, before being submitted to a journal. The value and importance of preprints has grown since its contribution during the public health emergency of the COVID-19 pandemic. Funders and publishers are establishing their position on the use of preprints, in grant applications and publishing models. However, the eviden
Clinical Infectious Diseases
6.09.2023
AbstractBackgroundHPTN 083/084 trials showed up to 88% increased efficacy of long-acting cabotegravir (CAB-LA) versus continuous oral tenofovir/emtricitabine (TDF/FTC). However, CAB-LA’s high price limits the number who can be treated within fixed prevention budgets. Global HIV prevention budgets are highly limited, with TDF/FTC widely available as a low-cost generic. In randomised clinical trials, event-driven TDF/FTC has shown similar preventative efficacy to continuous TDF/FTC.MethodsA systematic revie
Infection
3.09.2023
rospectively enrolled and compared to a historical control group (n = 113). Comparisons were done using a propensity-score-based overlap-weighting model. Adherence to preventive measures was quantified by the study-specific ‘Preventing PSS score’ (PrePSS score) which includes pneumococcal and meningococcal vaccination status, the availability of a stand-by antibiotic and a medical alert card. . . . Results. At six months af
Infection
1.09.2023
rospectively enrolled and compared to a historical control group (n = 113). Comparisons were done using a propensity-score-based overlap-weighting model. Adherence to preventive measures was quantified by the study-specific ‘Preventing PSS score’ (PrePSS score) which includes pneumococcal and meningococcal vaccination status, the availability of a stand-by antibiotic and a medical alert card. . . . Results. At six months af
Journal of Acquired Immune Deficiency Syndromes
1.09.2023
Introduction: . Expanding HIV Pre-Exposure Prophylaxis (PrEP) use is key to goals for lowering new HIV infections in the U.S. by 90% between 2022 and 2030. Unfortunately, youth aged 16-24 have the lowest PrEP use of any age group and the highest HIV incidence rates. Methods: . To examine the relationship between HIV seroconversion and PrEP uptake, adherence, and continuity, we used survival analysis and multivariable logistic regression on data of 895 youth at-risk for HIV infection enrolled in Adolescent
FEMS Microbiology Reviews
20.08.2023
AbstractUnderstanding the origins of past and present viral epidemics is critical in preparing for future outbreaks. Many viruses, including SARS-CoV-2, have led to significant consequences not only due to their virulence, but also because we were unprepared for their emergence. We need to learn from large amounts of data accumulated from well-studied, past pandemics and employ modern informatics and therapeutic development technologies to forecast future pandemics and help minimize their potential impacts.
Lancet
18.08.2023
Last month, ahead of the International AIDS Conference in Brisbane, Australia, a landmark study published in The Lancet by Laura N Broyles and colleagues reported that people living with HIV who maintain low—but still detectable—levels of the virus (less than 1000 copies per mL) have almost zero risk of transmitting it to their sexual partners. It was a stunning result, adding compelling evidence to further bolster the undetectable equals untransmittable (U=U) HIV campaign. U=U means that individuals li
BMC Infectious Diseases
12.08.2023
. Abstract. . Background. To propose a new mode of HIV test and surveillance among population of men who have sex with men (MSM): Internet-based Self-sampling at home plus Laboratory testing of HIV total nucleic acid (TNA) in dried blood spot (DBS) (ISL of DBS TNA). Feasibility of ISL of DBS TNA was studied. Characteristics of the new mode and that of conventional surveillance mode at HIV voluntary counseling and testing cli
New England Journal of Medicine
6.08.2023
New England Journal of Medicine, Ahead of Print.
BMC Infectious Diseases
4.08.2023
. Abstract. . Background. To propose a new mode of HIV test and surveillance among population of men who have sex with men (MSM): Internet-based Self-sampling at home plus Laboratory testing of HIV total nucleic acid (TNA) in dried blood spot (DBS) (ISL of DBS TNA). Feasibility of ISL of DBS TNA was studied. Characteristics of the new mode and that of conventional surveillance mode at HIV voluntary counseling and testing cli
AIDS
3.08.2023
Objective: . Studies have shown varying trends in incidence of sexually transmitted infections (STI) among individuals using HIV pre-exposure prophylaxis (PrEP). Characterization of individuals at increased risk for STIs may offer an opportunity for targeted STI screening. Design: . Group-based trajectory modelling . Methods: . We screened participants from the AMPrEP demonstration project (2015–2020) for urogenital, anal, and pharyngeal chlamydia and gonorrhea, and syphilis every 3 months and when n
New England Journal of Medicine
27.07.2023
New England Journal of Medicine, Ahead of Print.
BMJ Open
21.07.2023
. Objective. Belgium has been hit harder by COVID-19 than other countries in Europe. While clinical risk factors are well studied, socioeconomic risk factors remained underexplored. This study’s objective was to analyse the social and clinical profile of patients hospitalised for COVID-19 during the two waves of 2020, compared with a control population in 2019 in two hospitals located in Brussels’ most deprived area. . Design and methods. We did a case–control study by using the minimal clinical data
Clinical Infectious Diseases
13.07.2023
AbstractWhile the Coronavirus Disease 2019 (COVID-19) pandemic continues to present global challenges, sufficient time has passed to reflect on lessons learned and use those insights to inform policy and approaches to prepare for the next pandemic. In May 2022, the Duke Clinical Research Institute (DCRI) convened a Think Tank with thought-leaders from academia, clinical practice, the pharmaceutical industry, patient advocacy, the National Institutes of Health, the US Food and Drug Administration (FDA), and
Clinical Microbiology and Infection
15.06.2023
Infectious disease pandemics and epidemics pose significant global threats, and the risk of emerging infectious diseases has increased due to factors such as international connections, travel, and population density. Despite investments in global health surveillance, much of the world remains unprepared to manage infectious disease threats.
AIDS
14.06.2023
Objective: . We evaluated PrEP initiation, persistence, and adherence measured via tenofovir-diphosphate (TFV-DP) concentrations in dried blood spots (DBS) among women offered PrEP during pregnancy. Methods: . We prospectively analyzed data from participants in the PrIMA Study (NCT03070600) who were offered PrEP during the 2nd trimester and followed through 9-months postpartum. At follow-up visits (monthly in pregnancy; 6 weeks, 6 months, 9 months postpartum), self-reported PrEP use was assessed, an
PLoS One Infectious Diseases
8.06.2023
k, Patricia Raccamarich, Nichole R. Klatt, Deborah L. Jones, Maria L. Alcaide . Background Miami, Florida is an epicenter of the HIV epidemic in the US, with 20% of new HIV infections occurring in women. Despite effectiveness of Pre-Exposure Prophylaxis (PrEP) in preventing HIV, only 10% of eligible women benefit from its use. Setting This study evaluates PrEP awareness and use, and factors associated with PrEP awareness among sexually active women in Miami, Florida. Methods Results reported in this stud
American Journal of Tropical Medicine and Hygiene
7.06.2023
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 108 Issue: 6 Pages: 1188-1191. .
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
Medscape Infectious Diseases
15.09.2023
On the cusp of respiratory virus season, experts offer their guidance to primary care physicians about how to advise patients about vaccines for COVID-19, influenza, and RSV. . Medscape Medical News
Eurosurveillance latest updates
16.03.2023
An individualised blood donor selection policy was implemented in the United Kingdom from summer 2021. We have investigated the impact of this policy by comparing the extent of undeclared use of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) before and after this change. The rate of PrEP usage in syphilis-positive male blood donors has not changed since individualised donor assessment was implemented but provides continuing evidence of undisclosed PrEP use which may be associated with current or p
Eurosurveillance latest updates
2.02.2023
Eurosurveillance latest updates
19.01.2023
Medscape Infectious Diseases
13.12.2022
"Since the launch of the medRxiv preprint server in 2019, the dissemination of research as preprints has grown rapidly, largely facilitated by the COVID-19 pandemic." . WebMD Health News
Medscape Infectious Diseases
8.12.2022
Preventive cancer screenings have not completely rebounded almost 3 years after the start of the pandemic, new research suggests. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
2.12.2022
This report describes appliances other than ovens used to cook frozen stuffed chicken products.
Eurosurveillance latest updates
24.11.2022
Eurosurveillance latest updates
20.10.2022
Medscape Infectious Diseases
7.10.2022
"When novel public health emergencies arise, extant ones cannot go by the wayside." .
ECDC COVID-19 updates
26.09.2022
This technical report presents an analysis focusing on three issues (testing and surveillance, healthcare sector coordination, and emergency risk communication) during the first phase of the COVID-19 pandemic.
Eurosurveillance latest updates
1.09.2022
ECDC COVID-19 updates
29.08.2022
This document sets out a number of scenarios that are intended to be plausible, internally consistent, and coherent descriptions of possible futures.
Medscape Infectious Diseases
15.06.2022
Educating primary care clinicians about preexposure prophylaxis for HIV could help ease the shortage in clinicians who prescribe the drugs, a study found. .
Medscape Infectious Diseases
24.05.2022
The FDA announced a June advisory committee meeting about COVID vaccines for kids younger than 6. The AMA has updated its billing codes ahead of an expected decision on Moderna's shot in this age group .
Medscape Infectious Diseases
19.05.2022
In trying to simplify recommendations and make rabies immunization less expensive, the CDC designated five risk levels with different advice based on the level of risk. .
Eurosurveillance latest updates
19.05.2022
WHO disease outbreak news
18.05.2022
As climate change is projected to significantly increase people’s exposure to heatwaves, and European weather services are expecting summers to be warmer and drier, WHO/Europe calls on countries to take measures to avoid adverse health impacts. .
Medscape Infectious Diseases
10.05.2022
University of Washington researchers tested a de-medicalized PrEP model at a sexual health clinic to increase PrEP initiation and retention. .